Approval for the i-factor peptide enhanced bone graft. This combination product is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from c3-c4 to c6-c7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit), with or without neck pain, or myelopathy due to a single-level abnormality localized to the disc space, and corresponding to at least one of the following conditions confirmed by radiographic imaging (ct, mri, x-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels, after failure of at least 6 weeks of conservative treatment. I-factor peptide enhanced bone graft p-15 putty must be used inside an allograft bone ring and with supplemental anterior plate fixation.
Supplemental Filings
Supplement Number | Date | Supplement Type |
P140019 | | Original Filing |
S007 |
2022-10-19 |
30-day Notice |
S006 |
2022-01-19 |
30-day Notice |
S005 |
2021-12-09 |
30-day Notice |
S004 |
2020-06-15 |
Normal 180 Day Track No User Fee |
S003 |
2019-04-17 |
Normal 180 Day Track No User Fee |
S002 |
2016-01-19 |
Normal 180 Day Track |
S001 |
2015-12-03 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices